Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma

被引:137
作者
Jadoul, P [1 ]
Donnez, J [1 ]
机构
[1] Catholic Univ Louvain, Clin Univ St Luc, Dept Gynecol, B-1200 Brussels, Belgium
关键词
atypical endometrial hyperplasia; endometrial adenocarcinoma; conservative treatment;
D O I
10.1016/S0015-0282(03)01183-X
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objective: To evaluate whether an alternative treatment to radical hysterectomy exists for young women with endometrial adenocarcinoma. Design: A review of the literature (70 articles) plus personal results. Setting: University hospital. Patient(s): Women with atypical endometrial hyperplasia or adenocarcinoma. Main Outcome Measure(s): The recurrence rate and the pregnancy rate after conservative therapy. Conclusion(s): Conservative treatment of well-differentiated stage I endometrial adenocarcinoma can be considered in young patients, with close surveillance to diagnose any possible recurrence. (C) 2003 by American Society for Reproductive Medicine.
引用
收藏
页码:1315 / 1324
页数:10
相关论文
共 74 条
[1]
ADASHI EY, 1996, REPROD ENDOCRINOLOGY, P1663
[2]
Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: Pathological, clinical, morphometric, and DNA-cytometric data [J].
Agorastos, T ;
Bontis, J ;
Vakiani, A ;
Vavilis, D ;
Constantinidis, T .
GYNECOLOGIC ONCOLOGY, 1997, 65 (01) :102-114
[3]
ASSESSMENT OF THE RISK ON ENDOMETRIAL CANCER IN HYPERPLASIA, BY MEANS OF MORPHOLOGICAL AND MORPHOMETRICAL FEATURES [J].
BAAK, JPA ;
WISSEBREKELMANS, ECM ;
FLEEGE, JC ;
VANDERPUTTEN, HWHM ;
BEZEMER, PD .
PATHOLOGY RESEARCH AND PRACTICE, 1992, 188 (07) :856-859
[4]
Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic Cooperative Oncology Group Study [J].
Bafaloukos, D ;
Aravantinos, G ;
Samonis, G ;
Katsifis, G ;
Bakoyiannis, C ;
Skarlos, D ;
Kosmidis, P .
ONCOLOGY, 1999, 56 (03) :198-201
[5]
A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens [J].
Bergeron, C ;
Nogales, FF ;
Masseroli, M ;
Abeler, V ;
Duvillard, P ;
Müller-Holzner, E ;
Pickartz, H ;
Wells, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (09) :1102-1108
[6]
Berlière M, 2000, EUR J CANCER, V36, pS35
[7]
Chatzaki E, 1996, CANCER RES, V56, P2059
[8]
COULAM CB, 1983, OBSTET GYNECOL, V61, P403
[9]
A phase II study of leuprolide in advanced/recurrent endometrial cancer [J].
Covens, A ;
Thomas, G ;
Shaw, P ;
Ackerman, I ;
Osborne, R ;
Lukka, H ;
Carey, M ;
Franssen, E ;
Roche, K .
GYNECOLOGIC ONCOLOGY, 1997, 64 (01) :126-129
[10]
CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO